Community sources variously attribute it to dose, to the DMSO carrier in transdermal use, or to vascular effects, with no way to confirm cause in self-reports
This protection extends to the scalp and hair follicles, potentially creating an environment more conducive to healthy hair growth
Tirzepatide, a dual-agonist peptide, has shown significant results with a 22.5% weight loss over 72 weeks at a 15 mg dose (Jastreboff et al., NEJM), making it one of the most effective therapies for obesity
Systemic copper absorption from intact skin is minimal at cosmetic concentrations, but no formal teratogenicity studies exist
The problem is usually insufficient deep sleep, specifically stage 3 slow-wave sleep, where the most critical restoration occurs